SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Indoco Remedies gets warning letter for Goa facility

17 Dec 2024 Evaluate

Indoco Remedies has received a warning letter from the US Food and Drug Administration (USFDA) for Plant II & Plant III facility located at Verna Industrial Estate Area, Verna, Goa, India (Facility) on December 17, 2024. This facility was inspected from July 16, 2024 to July 26, 2024. The Company remains committed to work closely with the USFDA and continues to enhance its compliance on an ongoing basis.

Earlier, the company had received Official Action Indicated (OAI) status from the USFDA for said facility. 

Indoco Remedies is engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs) in India.

Indoco Remedies Share Price

240.85 4.90 (2.08%)
07-Jul-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1903.00
Dr. Reddys Labs. 1353.75
Cipla 1452.35
Zydus Lifesciences 1152.90
Lupin 2489.85
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: